Luvixasertib (CFI-402257)
Product Specifications
CAS Number
1610759-22-2
Synonyms
Luvixasertib
SKU
C13298-5mg
Target
Serine/threonin kinase
Applications
Cell Cycle
Molecular Formula
C28H30N6O3
Additionnal Information
Luvixasertib (CFI-402257) is an inhibitor of threonine tyrosine kinase (TTK) with IC50 of 1.7 nM and Ki of 0.1 nM, respectively. It is a potential therapeutic for treating hepatocellular carcinoma that works directly by inhibiting cell-cycle checkpoints in cancer cells and indirectly by mobilizing immune cells from the tumor microenvironment.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNCB2406-500 1x 500 µL
Bcl-X (Apoptosis Marker) (BCL2L1/2406), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042024-100 1x 100 µL
Tyrosinase (Melanoma Marker) (TYR/2024R), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNCB2885-500 1x 500 µL
CD81 / TAPA-1 (C81/2885R), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 